...of the vimentin (VIM) gene. Under a 2009 deal, Exact Sciences has rights from the Mayo Foundation for Medical Education and Research...

...is expected in October or November. FDA’s approval triggered a $500,000 milestone payment to the Mayo Foundation for Medical Education and Research...

...average risk of developing colorectal cancer. FDA's approval triggers a $500,000 milestone payment to the Mayo Foundation for Medical Education and Research...

...based on lack of enablement or anticipation, for example. He cited Elan Pharmaceuticals Inc. v. Mayo Foundation for Medical Education and Research...
...NYSE:LLY), Indianapolis, Ind. Harvard University , Cambridge, Mass. Massachusetts Institute of Technology , Cambridge, Mass. Mayo Foundation for Medical Education and Research...

...assay will be jointly owned. Further terms were not disclosed. Cellumen Inc. , Pittsburgh, Penn. Mayo Foundation for Medical Education and Research...

...deal with the foundation (see BioCentury, July 31, 2006). Accentia Biopharmaceuticals Inc. (ABPI), Tampa, Fla. Mayo Foundation for Medical Education and Research...

...the IP to develop a test for that variant. Clinical Data Inc. (CLDA), Newton, Mass. Mayo Foundation for Medical Education and Research...

...under a deal with the Mayo Foundation. Laboratory Corp. of America Holdings (LH), Burlington, N.C. Mayo Foundation for Medical Education and Research...

...formulation of amphotericin B to treat chronic rhinosinusitis. Accentia acquired intranasal amphotericin B from the Mayo Foundation for Medical Education and Research...

...formulation of amphotericin B to treat chronic rhinosinusitis. Accentia acquired intranasal amphotericin B from the Mayo Foundation for Medical Education and Research...